| Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia JA Fraietta, SF Lacey, EJ Orlando, I Pruteanu-Malinici, M Gohil, S Lundh, ... Nature medicine 24 (5), 563-571, 2018 | 1351 | 2018 |
| High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response H Gao, JM Korn, S Ferretti, JE Monahan, Y Wang, M Singh, C Zhang, ... Nature medicine 21 (11), 1318-1325, 2015 | 1315 | 2015 |
| The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. L Shi, G Campbell, WD Jones, F Campagne, Z Wen, SJ Walker, Z Su, ... Nature biotechnology 28 (8), 827, 2010 | 847 | 2010 |
| Project DRIVE: a compendium of cancer dependencies and synthetic lethal relationships uncovered by large-scale, deep RNAi screening ER McDonald, A De Weck, MR Schlabach, E Billy, KJ Mavrakis, ... Cell 170 (3), 577-592. e10, 2017 | 598 | 2017 |
| Solid‐state NMR spectroscopic methods in chemistry DD Laws, HML Bitter, A Jerschow Angewandte Chemie International Edition 41 (17), 3096-3129, 2002 | 565 | 2002 |
| Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell M Ruella, J Xu, DM Barrett, JA Fraietta, TJ Reich, DE Ambrose, ... Nature medicine 24 (10), 1499-1503, 2018 | 541 | 2018 |
| The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1 AA Wylie, J Schoepfer, W Jahnke, SW Cowan-Jacob, A Loo, P Furet, ... Nature 543 (7647), 733-737, 2017 | 494 | 2017 |
| Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia EJ Orlando, X Han, C Tribouley, PA Wood, RJ Leary, M Riester, JE Levine, ... Nature medicine 24 (10), 1504-1506, 2018 | 469 | 2018 |
| Correlative analysis of genetic alterations and everolimus benefit in hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer … GN Hortobagyi, D Chen, M Piccart, HS Rugo, HA Burris, KI Pritchard, ... Journal of Clinical Oncology 34 (5), 419-426, 2016 | 265 | 2016 |
| Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for “active” disease R Peng, S Sridhar, G Tyagi, JE Phillips, R Garrido, P Harris, L Burns, ... PloS one 8 (4), e59348, 2013 | 241 | 2013 |
| Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression F Allantaz, DT Cheng, T Bergauer, P Ravindran, MF Rossier, M Ebeling, ... PloS one 7 (1), e29979, 2012 | 235 | 2012 |
| Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive … DT Cheng, DK Kim, DA Cockayne, A Belousov, H Bitter, MH Cho, ... American journal of respiratory and critical care medicine 188 (8), 948-957, 2013 | 174 | 2013 |
| Genomic analysis of nasopharyngeal carcinoma reveals TME-based subtypes L Zhang, KD MacIsaac, T Zhou, PY Huang, C Xin, JR Dobson, K Yu, ... Molecular Cancer Research 15 (12), 1722-1732, 2017 | 130 | 2017 |
| Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity DA Cockayne, DT Cheng, B Waschki, S Sridhar, P Ravindran, H Hilton, ... PloS one 7 (6), e38629, 2012 | 130 | 2012 |
| CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell H Bitter, JM Bordeaux, B Brannetti, J Brogdon, NK Dakappagari, S Gill, ... US Patent 10,253,086, 2019 | 117 | 2019 |
| Transcriptomic analysis of the woodchuck model of chronic hepatitis B SP Fletcher, DJ Chin, Y Ji, AL Iniguez, B Taillon, DC Swinney, ... Hepatology 56 (3), 820-830, 2012 | 107 | 2012 |
| Comprehensive regional and temporal gene expression profiling of the rat brain during the first 24 h after experimental stroke identifies dynamic ischemia‐induced gene … M Rickhag, T Wieloch, G Gidö, E Elmér, M Krogh, J Murray, S Lohr, ... Journal of neurochemistry 96 (1), 14-29, 2006 | 106 | 2006 |
| Reduction of HBV replication prolongs the early immunological response to IFNα therapy AT Tan, LT Hoang, D Chin, E Rasmussen, U Lopatin, S Hart, H Bitter, ... Journal of hepatology 60 (1), 54-61, 2014 | 101 | 2014 |
| Determination of the human cardiomyocyte mRNA and miRNA differentiation network by fine-scale profiling JE Babiarz, M Ravon, S Sridhar, P Ravindran, B Swanson, H Bitter, ... Stem cells and development 21 (11), 1956-1965, 2012 | 101 | 2012 |
| Acute myeloid leukemia case after gene therapy for sickle cell disease S Goyal, J Tisdale, M Schmidt, J Kanter, J Jaroscak, D Whitney, H Bitter, ... New England Journal of Medicine 386 (2), 138-147, 2022 | 96 | 2022 |
Sreekumar PillaiEli Lilly and CompanyVerified email at lilly.com
